Cramp-fasciculation syndrome in patients with and without neural autoantibodies

Muscle and Nerve

Volumn 49, Issue 3, 2014, Pages 351-356

  Liewluck, Teerin ^a,b   Klein, Christopher J ^a   Jones, Lyell K ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

CASPR2 antibody; Cramp fasciculation syndrome; LGI1 antibody; Peripheral nerve hyperexcitability syndrome; Voltage gated potassium channel complex antibody

Indexed keywords

AUTOANTIBODY; CARBAMAZEPINE; CONTACTIN ASSOCIATED PROTEIN 2; CREATINE KINASE; IMMUNOGLOBULIN G; LEUCINE-RICH GLIOMA INACTIVATED 1; NEURAL AUTOANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AFTERDISCHARGE; ANHIDROSIS; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CRAMP FASCICULATION SYNDROME; CREATINE KINASE BLOOD LEVEL; ELECTROENCEPHALOGRAPHY; ELECTROPHORESIS; FASCICULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERHIDROSIS; IMMUNOTHERAPY; MALE; MUSCLE BIOPSY; MUSCLE CRAMP; NERVE STIMULATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PARAPROTEINEMIA; POLYCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; TIBIAL NERVE; TONIC CLONIC SEIZURE;

CASPR2 ANTIBODY; CRAMP-FASCICULATION SYNDROME; LGI1 ANTIBODY; PERIPHERAL NERVE HYPEREXCITABILITY SYNDROME; VOLTAGE-GATED POTASSIUM CHANNEL COMPLEX ANTIBODY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOPHYSICS; CHILD; COHORT STUDIES; CREATINE KINASE; ELECTRIC STIMULATION; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; NEUROMUSCULAR DISEASES; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEINS; YOUNG ADULT;

EID: 84893966936     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23935     Document Type: Article

References (22)

1. Auger RG, Daube JR, Gomez MR, Lambert EH. Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol 1984;15:13-21.
2. Bodkin CL, Kennelly KD, Boylan KB, Crook JE, Heckman MG, et al. Defining normal duration for afterdischarges with repetitive nerve stimulation: a pilot study. J Clin Neurophysiol 2009;26:45-49.
3. Tahmoush AJ, Alonso RJ, Tahmoush GP, Heiman-Patterson TD. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021-1024.
4. Rubio-Agusti I, Perez-Miralles F, Sevilla T, Muelas N, Chumillas MJ, et al. Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology 2011;76:172-178.
5. Verdru P, Leenders J, Van Hees J. Cramp-fasciculation syndrome. Neurology 1992;42:1846-1847.
6. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995;38:714-722.
7. Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology 2000;54:771-772.
8. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve. 2002;26:702-707.
9. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887-1895.
10. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883-1890.
11. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-78.
12. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
13. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
14. Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303-311.
15. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012;72:241-255.
16. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004;56:715-719.
17. Apiwattanakul M, McKeon A, Pittock SJ, Kryzer TJ, Lennon VA. Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve 2010;41:702-704.
18. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium-complex autoimmunity. Neurology 2012;79:1136-1144.
19. Hart IK, Waters C, Vincent A, Newland C, Beeson D, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.
20. Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, et al. Insight from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 2013;70:229-234.
21. Rana SS, Ramanathan RS, Small G, Adamovich B. Paraneoplastic Isaac' syndrome: a case series and review of literature. J Clin Neuromusc Dis 2012;13:228-233.
22. Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012;69:582-593.